Bypassing the Stratum Corneum for Enhanced Transdermal Delivery

You are reading version 1 of this direction, frozen 2026-10-04. The latest version is version 2.

Version 1 of 215 papers19 conceptsfrozen 2026-10-04

The human skin is an evolutionary masterpiece of defense. Its outermost layer, the stratum corneum, functions as a biological brick wall: a dense matrix of keratin-filled cells embedded in highly ordered lipid domains. While this barrier is essential for keeping pathogens out and water in, it presents a formidable obstacle for modern medicine. Most therapeutic compounds—especially large, hydrophilic, or highly hydrophobic molecules—simply cannot pass through this layer in concentrations high enough to be effective.

To move beyond simple topical creams, researchers are developing "chemical crowbars," mechanical bypasses, and nano-scale carriers designed to navigate or temporarily dismantle this barrier.

Mechanical Bypasses: The Microneedle Revolution

The most direct way to overcome a wall is to poke holes in it. Microneedles create temporary microchannels through the stratum corneum, allowing drugs to reach the viable epidermis and dermis without triggering the pain receptors located deeper in the skin.

However, early mechanical approaches faced safety hurdles. Brittle materials like silicon posed a risk; if a needle snapped off, it could remain lodged in the skin, causing irritation or infection. Jiashen Wei addressed this by developing hybrid arrays with biodegradable porous silicon tips (Silicon microneedles array with biodegradable tips for transdermal drug delivery), ensuring that any material left behind would safely dissolve.

Recent work has shifted toward dissolving microneedles (DMNs), which serve as both the delivery vehicle and the drug itself. These patches can deliver complex payloads:

Chemical Crowbars and Natural Enhancers

When mechanical bypass isn't feasible, researchers use chemical penetration enhancers to fluidize the stratum corneum's lipid bilayer. These substances temporarily disrupt the "mortar" between the skin's "bricks."

HM Ji and Yu‐Ju Chen demonstrated that turpentine oil acts as a potent chemical enhancer for Ketorolac patches, significantly increasing the rate at which the painkiller enters the bloodstream (Penetration Enhancement Effect of Turpentine Oil on Transdermal Film of Ketorolac). Similarly, natural polymers like cashew bark exudate gum and elephant apple fruit gum have been used by Poonam Rishishwar to create gels that improve the permeation of lidocaine, offering a sustainable alternative to synthetic stabilizers (USE OF CASHEW BARK EXUDATE GUM IN THE PREPARATION OF 4 % LIDOCAINE HCL TOPICAL GELS).

The Challenge of Diseased Skin

The delivery problem is compounded in chronic conditions like psoriasis. Here, the skin undergoes hyperkeratosis—a pathological thickening of the stratum corneum that creates an even tougher barrier.

Research by Lipeng Tang highlights that conventional topicals often fail because they cannot reach the deeper inflammatory sites beneath these thick, scaly plaques (Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription). Interestingly, Manfred Bodenlenz discovered that this thickened tissue can act as a "trap" or reservoir, sequestering drugs and slowing their movement into the body (Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin). As the skin heals and thins, the penetration kinetics begin to normalize, suggesting that dosing may need to be dynamic throughout the treatment cycle.

Nano-scale Carriers and Molecular Engineering

The latest frontier involves packaging drugs into specialized nanostructures that "trick" the skin into allowing passage.

By combining these mechanical, chemical, and nano-scale strategies, the field is moving toward a future where "topical" treatment is no longer synonymous with "superficial" treatment.

Papers in this version

History & citationVersion 2 · 2026-10-04

Current · Permanent link

  1. Version 2 (latest) · 2026-10-04 · 21 papers
  2. Version 1 · 2026-10-04 · 15 papers
Cite this direction

Latest version (a living page):

@misc{lacuna_stratum_corneum_barrier_8164d469,
  title = {stratum corneum barrier},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/stratum-corneum-barrier/rdr_8164d469752c4ed69a9c9c2fe49965d0},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_bypassing_the_stratum_corneum_for_enhanc_8164d469_v1,
  title = {Bypassing the Stratum Corneum for Enhanced Transdermal Delivery},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/bypassing-the-stratum-corneum-for-enhanced-transdermal-delivery/rdr_8164d469752c4ed69a9c9c2fe49965d0/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}